Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)
Clinical trial NCT02435680 · COMPLETED
Trial details
- NCT number
- NCT02435680
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-10
- Primary completion
- 2020-01-04
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.